Diagnosing FCS
Patient case: Gus
Gus, aged 31, presents with persistently elevated triglyceride levels and a medical history that prompts further evaluation.
He complains of lethargy and brain fog, and continues to experience severe abdominal pain despite having seen multiple gastroenterologists and receiving a diagnosis of irritable bowel syndrome. For the past 2 years, he estimates that he's missed about 3 days of work each month.
Key findings:
- Diagnosed with severe hypertriglyceridemia (sHTG) at age 9
- Fasting triglyceride levels >1500 mg/dL that have been consistently refractory to lipid-lowering treatments
- History of recurrent abdominal pain
- No known secondary causes of sHTG (eg, certain medications, alcohol use, metabolic syndrome)
- Body mass index (BMI) of 21.3
- Total cholesterol=175 mg/dL
- Apolipoprotein B (apoB)=85 mg/dL
Hypothetical patient case; actor portrayal.
Based on a clinical assessment and genetic testing, Gus is diagnosed with FCS.
Key clinical features of FCS19
These indicators call for a consideration of an FCS diagnosis:
Fasting triglyceride levels of ≥880 mg/dL that are refractory to standard triglyceride-lowering therapies
No known secondary causes for their sHTG*
Recurrent abdominal pain or history of acute pancreatitis
Hypertriglyceridemia can be caused by medications such as glucocorticoids, ethinylestradiol, and neuroleptics, or conditions such as uncontrolled diabetes, hypothyroidism, and pregnancy.19FCS=familial chylomicronemia syndrome; sHTG=severe hypertriglyceridemia.
Genetic testing and clinical scoring can support an FCS diagnosis
Ionis has partnered with PreventionGenetics to provide no-cost, confidential genetic tests for eligible patients who†:
- Have evidence of severe refractory hypertriglyceridemia, defined by a minimum of 2 consecutive fasting triglyceride levels ≥880 mg/dL or 10 mmol/L
- Lack secondary causes known to cause sHTG
- Are residents of the United States
PreventionGenetics Brochure
Download an overview of FCS patient identification, diagnostic scoring tools, and no-cost genetic testing
No-cost genetic testing is also available
through Genome Medical
at 1-888-478-1494.
To learn more about no-cost genetic testing, click here.
FCS clinical scoring tools are also available to support diagnosis5,19:
- The North American FCS (NAFCS) Score: Developed in 2024 and validated specifically in North American patients
- Clinical criteria developed by Moulin et al: A panel of European experts developed an algorithm-based diagnostic tool that was published in 2018
†Tests must be ordered by a qualified healthcare professional and informed consent must be provided by the patient.
Note that other companies also offer genetic testing services for FCS.
FCS= familial chylomicronemia syndrome. sHTG=severe hypertriglyceridemia.